Introduction
Development begins with a fertilized oocyte that gives rise to diverse cells with differing fates. Current models of development are based primarily on the molecular embryology of Drosophila and postulate a hierarchy of regulatory genes guiding the transfer of genetic information into embryonic structures (reviewed in Akam, 1987; Ingham, 1988) . Establishment of diverse cell fates during embryogenesis requires differential gene expression that is modulated by specific regulatory proteins (reviewed in Davidson, 1990) . The identification of murine regulatory proteins specific for early stages of embryogenesis might unravel important members of a regulatory hierarchy in the mouse.
Members of a family of Oct-proteins bind to the octamer motif (Scholer et al., 1989a) Schreiber et al., 1989) . In undifferentiated embryonal carcinoma (EC) cells, the octamer motif mediates both transcriptional activation (Scholer et al., 1989b) and repression (Lenardo et al., 1989) . Three octamer binding proteins might account for these opposite activities, namely Oct4, Oct-5 and Oct-6 (Scholer et al., 1989a) . Oct-4 and Oct-5 are encoded by the Oct-4 gene (Scholer et al., l990a; 1990b) .
Here we report the cDNA sequence of the third EC octamer binding protein Oct-6 as well as its expression during mouse development. The cDNA encodes a protein of 448 amino acids containing a POU domain identical to Tst-l and SCIP (He et al., 1989; Monuki et al., 1989) . A stretch of 8 amino acids between the potential helices 1 and 2 of the POU homeodomain has been conserved between both EC proteins Oct-6 and Oct-4, although both proteins otherwise diverge. Ectopic expression of Oct-6 cDNA was sufficient to activate transcription from the octamer motif, indicating that Oct-6 is a transcription factor. Expression of the Oct-6 gene during embryogenesis was analyzed by in situ hybridization, Northern blot analysis, RNase protection and DNA binding studies. We demonstrate Oct-6 expression in embryonal stem cells and in developing brain and adult testis. With the proteolytic clipping assay the presence and identity of Oct-6 in brain cortex is shown. These studies suggest that the transcription factor Oct46 might control events at very early and late stages of murine development.
Results
Identification of cDNA clones encoding Oct-6 Four DNA-protein complexes are detectable with the octamer motif in undifferentiated F9 EC cells in the electrophoretic mobility shift assay (EMSA) (named Oct-i, Oct-4, Oct-5 and Oct-6 according to Scholer et al., 1989a) . A cDNA library prepared from F9 cells was screened with a probe spanning the mouse Oct-2 POU domain (Hatzopoulos et al., 1990) . Three groups of clones encoding octamer binding proteins were isolated. Clones of the first group encoded Oct-I and those of the second Oct-4 and Oct-5 (Scholer et al., 1990a) . About one-third of the recombinant clones, comprised a third group and were tentatively assigned as incomplete Oct-6 clones.
These cDNAs encode a protein with a POU domain identical to rat Tst-I and SCIP (He et al., 1989; Monuki et al., 1989) . Probes from both, Tst-1 and SCIP, detect brain mRNA (He et al., 1989; Monuki et al., 1989) . The POU domain of Tst-l/SCIP is alinost identical to Bin-I and Brn-2 (He et al., 1989 Alanine/glycine-rich sequences are underlined.
clones and lacking any POU sequences (probe A; Figure   IA ). the probe hybridized to a 2.3 kb mRNA, in brain and testis RNA but not in F9 RNA. The 3.6 kb RNA represents the major Oct-6 mRNA in F9 stem cells and brain. In testis each RNA species is found less abundant and in approximately equimolar amounts. The lengths of these mRNAs are distinct from those found in testis and brain of adult rat where they are 4.4 and 7.6 kb, respectively (He et al., 1989) . The predominant 3.6 kb Oct-6 mRNA might correspond to the predominant Tst-1/SCIP species (3 kb) in postnatal and young adult rats (Monuki et al., 1989) .
RNase protection assays confirmed the identity of the reactive RNAs as authentic transcripts of the Oct-6 gene ( Figure 2B ). Anti-sense RNA was prepared from the same fragment as used for the Northern blot analysis. Again, Oct-6 transcripts were detected in F9 cells, in brain and in testis ( Figure 2B ; testis RNA not shown), again no signal was obtained with RNA from differentiated F9 cells (Figure 2A and B). Thus the decrease of Oct-6 RNA correlates with the decrease of Oct-6 binding activity during F9 stem cell differentiation (Scholer et al., 1989a) . Using the RNase protection assay the analysis was extended to the embryonal stem (ES) cell line D3 (Doetschman et al., 1985) ( Figure  2B ). Because ES cells are totipotent stem cells derived from the inner cell mass of murine blastocysts (Gardner and Rossant, 1979; Evans and Kaufman, 1981; Martin, 1981) Figure 2B ). Finally, expression was examined in mouse embryos from day 10 to day 15. Weak expression was detected at embryonic day 10 and day 11, respectively. By day 12 a strong signal was obtained, indicating that Oct-6 expression increases significantly at about embryonic day 11 ( Figure  2B ). embryos from day 10 to day 17 were analyzed ( Figure 3 ). Continuous expression in defined regions of prosencephalon (pe), mesencephalon (mes) and rhombencephalon (rhe) was observed ( Figure 3 ). Brains of day 10 embryos showed faint expression in cell clusters in the floor plate of the prosencephalon, mesencephalon and rhombencephalon as well as in the mesencephalic roof ( Figure 3A and B). By day 12 expression in these areas had increased significantly ( Figure 3C and D). Two distinct cell groups were visible in the prosencephalic floor, one in the ventral half of the prospective striatum (pe 1), the other in a region that gives rise to the thalamus (pe 2). The prosencephalic roof, which develops into the diencephalic roof plate, was also positive for Oct-6 expression. In the mesencephalon, expression included the ventral mesencephalic flexure. A signal was detectable in the mesencephalic roof, which gives rise to superior (sc) and inferior (ic) colliculi and also in the metencephalon which gives rise to the cerebellum (cb). Oct-6 expression was found also in the developing pons (pn) and myelencephalon/medulla (my). All zones of expression are within the intermediate layer of the developing central nervous system, where neurons and glioblasts start to differentiate (Rickman and Wolff, 1985) .
At day 14 the number of Oct-6 positive cells in the intermediate layer had increased and formed aggregates. Expression was found within the ventral pons and the ventral medulla. Positive cell aggregates were found ventral of the prospective striatum, along the mesencephalic flexure, and within the thalamus (not shown). In addition, expression was detected in the developing cerebral cortex, olfactory bulb (ob), but not within the cerebellum. Oct-6 expression was also found in the superior colliculi and strongly in the inferior colliculi of the mesencephalic roof. Both colliculi serve as centers for visual and auditorial correlation. The superior colliculi are primary receptive centers for the optic tracts and are linked to the inferior colliculi which, in turn, connect with the cochlear nuclei of the pons.
A similar pattern was observed for day 16 and day 17, with increased expression in the cerebral cortex (Figure 3 I to L) . Expression continued in the cerebral cortex and the olfactory bulb of adult mice, whereas superior colliculus and the thalamus were negative for Oct-6 expression (not shown).
In situ hybridization was also used to investigate Oct-6 transcription at the blastocyst stage. However, in contrast to results obtained with the Oct4 gene (Scholer et al., 1990b) , Oct-6 transcripts could not be detected (data not shown).
Expression of Oct-6 protein in embryonal stem cells and in the developing brain In a previous report we described a DNA protein complex specfic for the frontal cortex and subcortical regions of rat brain (Scholer et al., 1989a) . Prolonged electrophoresis showed that the mobility of this complex was identical to that of F9 Oct-6 and slightly higher than that of brain Oct-3. The brain-specific protein had been originally named Oct-3 by us (Scholer et al., 1989a) but unfortunately the same term is now used by others (Okamoto et al., 1990; Rosner et al., 1990) for the Oct-4 protein (Scholer et al., 1989a, b; 1990a, b) . To distinguish F9 Oct-3 from brain Oct-3 and to avoid further ambiguities, those octamer-binding proteins that are expressed in the nervous system will be named NOct proteins.
As a first step to determine the relationship of F9 Oct-6, amw Oct-4 fd s OCt NOct-6 and NOct-3 we examined if Oct-6 is modified in vivo. For this purpose, Oct-6 prepared by in vitro translation of the Oct-6 cDNA was compared in the EMSA with Oct-6 produced ectopically in HeLa cells (for expression details see below). In both cases the protein gave a band at the same position, indicating that Oct-6 is either not modified in HeLa cells or that the modification is not detectable in the EMSA ( Figure 4A ). Next we examined if cells and tissues containing Oct-6 RNA give a complex with identical mobility in the EMSA. Therefore, the Oct-6 protein was expressed in HeLa cells and compared with F9, D3 and cortex extracts ( Figure 4B ). Cerebellum of newborn mice was used as a negative control, as Oct-6 RNA had not been found by in situ analysis. Moreover, cerebellum extract gives most of the Oct complexes in the EMSA; the complexes not found in cerebellum, are in extracts of F9, D3 or cortex. Each source that had been shown to be positive for Oct-6 RNA gave a complex at the expected position (compare lane 6 with lanes 1 to 3), whereas the cerebellum is negative for both Oct-6 RNA and NOct-6 protein (lane 4). In this experiment the presence of Oct-6 RNA correlates with that of the NOct-6 complex.
The analysis of the NOct-6 complex was initially hindered (Figure 6 ). Only a weak Oct-6 signal is detectable at embryonic day 12 or 15, much less prominent than NOct-3 (lanes 1 to 6). Subsequently, a complex is found both in cortex and brain extracts, whereas Oct-6 remained absent in every extract derived from cerebellum (lanes 7 to 19). In summary, the Oct-6 complex is faintly detectable in brain of day 12 embryos, increasing significantly thereafter in cortex and brainstem. Thus the appearance of the Oct-6 complex follows that of Oct-6 RNA. In addition to the Oct-complexes described previously (Scholer et al., 1989a) a complex with the same mobility as Oct-2B could be identified in brainstem and metencephalon ( Figure 6 ). (Poole et al., 1985; McDonald et al., 1986; Frasch et al., 1987) .
Second, a histidine rich region (30%) is found from position 185 to 228 amino-terminal to the POU domain. This includes alternating histidine and glycine (or alanine) residues (HLGAHGHAHGHAHA) and a cluster of four acidic amino acids. A similar alternating sequence motif (HGLGHGHKHGHGHG) is found also in the histidine-rich region of high molecular weight (HMW) kininogen (Kato et al., 1983; Lottspeich et al., 1985) . Interestingly, this region is associated with the clotting activity of HMW kininogen. In bovine HMW kininogen a 41 amino acid fragment (fragment 2; 27% histidine) with this motif is released by the action of plasma kallikrein, and hereby the clotting activity is lost (Iwanaga et al., 1979) .
Third, proline residues distributed throughout the aminoterminal half of Oct-6 are interspersed with twelve acidic and seven basic amino acids. Another region harboring both proline and acidic amino acid residues follows the POU domain. Whether any of these acidic regions participate in transcriptional activation, as has been described for other acidic domains, remains to be tested (reviewed in Mitchell and Tjian, 1989) .
Finally, contiguous stretches of six proline and of six histidine residues each are found at the carboxy-terminus of Oct-6. Even longer rows of proline and histidine residues are found in other proteins, although, again their significance is unknown. For example, two stretches of ten and eight histidine residues are found in Drosophila polycomb 3728 Fig. 7 . Predicted amino-acid sequence (single-letter code) of Oct-6. The POU specific domain and the POU homoeodomain -and + indicate acidic and basic amino acids, respectively. Histidine residues are boxed and proline residues are circled. The cysteine residues are underlined with thick bars.
(R.Paro, personal communication). Polyproline stretches are found in several viral proteins. For example, the activity of the HSV transactivator VP16 is increased by another viral protein with a polyproline at the carboxy-terminus (McKnight et al., 1987) .
Transactivation by cloned Depending on the context of other transcription elements, the octamer motif confers transcriptional activation (Scholer et al., 1989b) or repression (Lenardo et al., 1989) 
The transactivation activity of Oct-6 was compared with that of Oct-2A (Miiller-Immergliuck et al., 1988) and of Oct-4 (Scholer et al., 1990b) . For this purpose, the Oct-6 coding sequence was cloned in both orientations into an eukaryotic SV40 expression vector ( Figure 8C ). The expression plasmids were transfected into HeLa cells together with ,B-globin reporter plasmids containing either a normal or a mutated octamer site in front of the 3-globin TATA box ( Figure 8D ). Both target vectors carry a SV40 enhancer downstream of the g-globin gene. This particular arrangement of TATA box and octamer motif is transactivated by Oct-2A (Muller-Immerfluck et al., 1988; 1990) .
Expression of Oct-6, Oct4 and Oct-2A were confirmed by the EMSA (Figure 8A ). In the absence of a functional The reporter plasmids and their analysis are described by Muller-Immergluck et al. (1988; 1990) .
transactivator ( Figure 8A , lanes 4 and 5), f-globin expression was not detectable ( Figure 8B , lanes 5, 6, 9 and 10). However, cotransfection of functional Oct-6 induced gene expression significantly via the octamer motif (lanes 7 and 8). This stimulation is comparable to that of Oct-2A and Oct-4 (lanes 1 and 3), clearly demonstrating that Oct-6 functions as a transactivator. The 6W enhancer, containing six tandem repeats of a mouse immunoglobulin heavy chain gene enhancer fragment, is highly active in F9 stem cells where Oct-4 and Oct-6 are present (Scholer et al., 1989b) . Because transactivation experiments in HeLa cells with cloned Oct-4 were not successful (Scholer et al., 1990b) , we wanted to determine if Oct-6 is responsible for enhancer activation. For this purpose, we used the same reporter vectors as for the Oct4 analysis (Scholer et al., 1990b) , but again transactivation of the 6W enhancer could not be achieved (not shown). Therefore, none of the cloned octamer binding porteins show enhancer activation but can only activate via an octamer motif near the TATA box (Muller-Immergluck et al., 1988; 1990; Scholer et al., 1990b; Tanaka and Herr, 1990; Okamoto etal., 1990 ).
Discussion
We have reported cloning of a cDNA encoding the new transcription factor Oct-6 activating transcription via the octamer motif. As with the other embryonal stem cell protein, Oct-4, Oct-6 is downregulated upon differentiation, but is later expressed again in cells of the developing brain and in testis. The temporal and spatial expression of Oct-6 was analyzed by Northern blot analysis, RNase protection, in situ hybridization and DNA binding studies. A clear correlation of Oct-6 RNA and Oct-6 protein is shown. The proteolytic clipping assay confirmed the presence and identity of Oct-6 as one of several octamer binding proteins in brain.
Oct-6 is encoded by the isolated cDNA Several lines of evidence indicate that the cDNA described in this study encodes Oct-6. First, four octamer binding proteins (Oct-1, Oct-4, Oct-5 and Oct-6) were detected in F9 stem cells. 18 clones from the F9 cDNA library fall into three different groups, two encoding Oct-l, and Oct-4/Oct-5 (Scholer et al., 1990a) . The third group comprises five cDNA clones of a new gene coding for an octamer binding POU protein. Second, the RNA detected with an Oct-6 specific probe is in agreement with the presence of DNA binding activity. Third, brain Oct-6 is identified due to its clipping pattern as the protein encoded by the cloned Oct-6. Finally, the protein encoded by the cDNA has the same mobility in the EMSA as F9 Oct-6 and brain Oct-6. The brain and F9 Oct-6 cDNA clones are identical, except for 500 bp missing at the 5'end of the F9 cDNA. Thus we cannot exclude the different exons are used for generating the amino-terminus, although F9 and brain Oct-6 have the same size in the EMSA, and the 3.6 and 2.8 kb Oct-6 mRNAS are found both in brain and in F9 cells.
Relationship of mouse Oct-6 and rat Tst-1ISCIP The identity of the POU domain sequence indicate that Oct-6 and Tst-l (He et al., 1989) and SCIP cDNAs (Monuki et al., 1989) are derived from homologous genes in mouse and rat. A comparison of the restriction maps of Oct-6 and SCIP supports this notion. The POU domain of both proteins is located close to the carboxy terminus. Furthermore, each restriction site in the SCIP coding region (Apal, PstI, SacIl) is found at a similar position in that of Oct-6, although Oct-6 has additional sites not found in SCIP (SacI, Kpnl) . The different mRNA sizes and expression patterns might be due to species specific differences, but might also indicate expression from a different gene. This is not unlikely, because several members of POU class III are almost identical (He et al., 1989) .
In the EMSA brain Oct-6 and NOct-3 almost have the same mobility. However, the proteolytic clipping pattern of both clearly demonstrate that both proteins are different ( Figure 5) . Moreover, NOct-3 is present where Oct-6 RNA is not found (Figures 3 and 6) . Therefore both proteins are most likely derived from different genes and not due to different modifications of the same protein. Candidates for genes encoding NOct-3 are Bn-I and Bm-2 which are both expressed in most regions of the rat brain (He et al., 1989) . NOct-3 is probably not encoded by Brn-3, because Brn-3 RNA is not found in rat cortex, whereas NOct-3 protein is. (Scholer et al., 1990b (Figure 2 ).
Oct-6 expression during the migratory phase of cortical neurogenesis is readily detectable in the cortical plate, subependymal zone and in the olfactory bulb. The widespread distribution of expression at embryonic day 12 and 14 and its expression in the cortical plate at day 17 indicate that Oct-6 is expressed in differentiating neurons. This is similar to Tst-1ISCIP expression in rat brain (He et al., 1989) . However, at least two differences are found between rat Tst-1ISCIP and mouse Oct-6 expression. In contrast to decreasing Tst-IISCIP expression during brain development, Oct-6 expression increases during the same period. Furthermore, in contrast to Tst-1ISCIP expression in rat cerebellum, no Oct-6 expression was detectable in this brain region. Tst-1ISCIP is expressed by myelinating glial cells (Schwann cells and oligodendrocytes), but not by nonmyelinating glia (astrocytes) . Because expression of Tst-1ISCIP precedes induction of the major myelin genes, it might play a role in cell-type specific expression of these genes (Monuki et al., 1989) .
Oct-6 protein is present in embryonal stem cells and in the developing brain. Therefore this transcription factor could be regulating different aspects of development. Since Oct-6 expression is turned down upon differentiation of ES cells and is strongly increased at about day 11, the Oct-6 gene might be expressed in a biphasic manner. In the first phase it might act prior to other putative control genes, such as Hox or Pax genes (reviewed in Dressler and Gruss, 1988; Holland and Hogan, 1988; Kessel and Gruss, 1990) . In the latter case it might take part in setting up the temporal and spatial patterns in mammalian brain development. Moreover, because Oct-6 is also found in cells of the adult brain, it might also be required for the maintenance of certain cellular functions and thus act, similar to Oct-2, as a cell-specific transcription factor.
The expression of Oct-6 is reminiscent of Drosophila homeodomain genes such as fushi tarazu (ftz), which is expressed early in development to play a critical role in pattern formation, and later reappears in a limited number of neurons (Doe et al., 1988) . Another protein, the Cfla gene product of Drosophila binds to a DNA element required for expression of the dopa decarboxylase in selected dopaminergic neurons (Johnson and Hirsch, 1990 Oct-6: activator, repressor or both? Oct-6 and Oct-4 are two positively regulating transcription factors present in ES and EC cells (Lenardo et al., 1989; Scholer et al., 1989a,b; Scholer et al., 1990a,b; Okamoto et al., 1990; Rosner et al., 1990) . Repression and activation via the octamer motif has been described in F9 cells (Lenardo et al., 1989; Scholer et al., 1989b) . Repression was shown with an immunoglobulin heavy chain gene enhancer fragment harboring the AcE3, ttE4 and octamer sites placed in front of a truncated promoter of the fos gene (Lenardo et al., 1989) . The positive effect of AE3 on the promoter was blocked by binding of proteins to the octamer motif. It remains to be tested, which octamer binding protein is responsible for repression. However, it would not be surprising if one or both of the cloned Oct-genes is responsible for both activities, because activation and repression have been described for several other eukaryotic transcription factors (reviewed in Levine and Manley, 1989) .
Oligomerization of the octamer motif creates a potent enhancer in ES and EC cells (Sch6ler, 1989b) . However, transactivation of this enhancer in HeLa cells by cloned Oct-4 and Oct-6 could not be achieved. Therefore either an inhibitory factor present in HeLa cells or a stimulatory factor present in the ES and EC cells but missing in HeLa, might account for this effect. Interestingly, both ES proteins contain the same stretch of eight amino acids located between helix one and two of the POU homoeodomain and thus might form an identical hinge. Both helices surrounding this sequence show about 40% homology to Oct-4, the highest homology of the Oct-4/Oct-6 hinge to members of the other POU classes (according to He et al., 1989 ) is 50%. We speculate that this conserved amino acid reflects an interaction with another protein. This would be similar to the interaction between the HSV protein VP16 with Oct-I (Gerster et al., 1988; Triezenberg et al., 1988; Kristie et al., 1989) at the next hinge between helix two and three (Stern et al., 1989) . Expression of VP16 in cells merely containing Oct-I activates the octamer motif in otherwise inactive promoters Tanaka et al., 1988) . Whether a similar interaction between the conserved Oct-4/Oct-6 hinge with a (stem cell specific) factor exists, and particularly, if enhancer activation in stem cell is due to such an interaction, will be tested.
Oct-6 is present in ES cells, in the developing and in the adult brain. Therefore this transcription factor could be regulating very early developmental proceses, acting prior to other putative control genes, such as Pax or Hox genes. It will be interesting to determine if Oct-6 regulates members of these families (Kessel and Gruss, 1990 Hogan et al., (1986) .
Cell lines and transfections for transactivation HeLa, F9 and D3 cells were grown and transfected as described elsewhere (Scholer and Gruss, 1984; Scholer et al., 1989a, b) . HeLa cells were transfected by 8 Ag reporter plasmid, 4 Ag expression vectors and 1 jg reference plasmid and 7 Ag Bluescript as carrier DNA. After harvesting of the cells two days later, 1/10 of the cells were used for the microextraction procedure. The RNA of the rest was extracted and analyzed by RNase protection. The transactivation analysis was done twice.
Preparation of the F9 and brain cDNA library A directional cloned F9 cDNA library in the X expression vector XZAPII (Stratagene) was constructed as described (Scholer et al., 1990a) , a mouse brain cDNA library in the X expression vector XZAPII was constructed with the cDNA synthesis kit (Pharmacia) in accordance with the manufacturer's specification. Sequencing was performed as described previously (Scholer et al., 1990a) .
Recombinant plasmids and oligonucleotides SV-Oct6+ and SV-Oct6-were obtained by cloning the complete coding sequence in a SV40 expression vector based on pBR322. Expression is driven by the SV40 enhancer/promoter region (Pvull to HindIII), one 72 bp deleted in the SV40 enhancer (Tooze, 1981) . A 610 bp Sau3A fragment ofSV40 with the small t-intron and a 257 bp SV40 fragment (BcII to BamHI) with transcriptional termination sequences follow the promoter fragment. The Hindi between promoter and t-intron was converted to Bgll. For cloning of Oct-6 the plasmid containing the Oct-6 cDNA was cut with Hindu and BamHI in the polylinker upstream and downstream of the cDNA, respectively. The ends were blunt-ended and cloned in both orientations into the blunt-ended Bgll site of the expression vector. The orientation of the insert was determined by restiction with X7hoI and BanHI. CMV-ct4+ and CMV-Oct4-clone were described by Scholer et al. (1990b) , CMV-Oct2A(+) by Muller-Immergluck et al. (1988) . The octamer containing probe was also described previously (1W in Scholer et al., 1989a) .
In vitro translation in reticulocyte lysates In vitro transcription and translation of Oct-4 and Oct-6 was performed as described previously (Scholer et al., 1990a) . Before in vitro transcription the Oct-6 cDNA clone was restricted with BamHI to obtain sense RNA with T7 RNA polymerase or with HinduI to obtain anti-sense RNA with T3 RNA polymerase.
Microextraction procedure for the preparation of whole extracts, electrophoretic mobility shift assay (EMSA) proteolytic clipping These methods were performed as described previously (Scholer et al., 1989a; 1990b) .
Northern blot analysis and RNase protection assay Northern blot analysis was performed as described previously (Scholer et al., 1990a) . RNase protection assays were performed essentially as described by Balling et al., (1989) .
In situ hybridization The techniques employed for in situ hybridization are in Scholer et al., (1990b) . A 160 bp Oct-6 cDNA fragment (fragment A in Figure IA ) was cloned into Bluescript (Stratagene) and linearized with an appropriate restriction endonuclease. RNA probes were transcribed using T3 and T7 polymerases according to the manufacturer's instructions (Promega).
